Ibrutinib
ATC L01EL01 · 11 markets · 47 records
AU 11 records · 6 strengths
- 140 mgcapsuleImbruvicaIMBRUVICA ibrutinib 140 mg capsule bottle
- 140 mgtabletIMBRUVICA ibrutinib 140 mg film-coated tablet blister
- 280 mgtabletImbruvicaIMBRUVICA ibrutinib 140 mg film-coated tablet blister
- 420 mgtabletImbruvicaIMBRUVICA ibrutinib 140 mg film-coated tablet blister
- 560 mgtabletImbruvicaIMBRUVICA ibrutinib 140 mg film-coated tablet blister
Records without a stated strength · 1 Imbruvica
US 6 records · 6 strengths
CA 6 records · 6 strengths
GB 5 records · 5 strengths
ES 5 records · 5 strengths
TW 4 records · 3 strengths
- 140 mgcapsule"Switzerland" Imbruvica Capsules 140mg"瑞士"億珂膠囊140毫克、Imbruvica、億珂膠囊140毫克
- 140 mgtabletImbruvica億珂膜衣錠140毫克
- 280 mgtabletImbruvica億珂膜衣錠280毫克
HK 3 records · 1 strengths
Records without a stated strength · 1 Imbruvica
CN 2 records · 1 strengths
- 140 mgcapsule亿珂伊布替尼
SG 1 records · 1 strengths
- 140 mgtabletImbruvica
MX 1 records · 1 strengths
- 140 mgtabletImbruvica
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Imbruvica
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | MX | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 140 mg capsule | Imbruvica | Imbruvica | Imbruvica | Imbruvica IMBRUVICA ibrutinib 140 mg capsule bottle | 亿珂伊布替尼 | Imbruvica | "Switzerland" Imbruvica Capsules 140mg "瑞士"億珂膠囊140毫克 Imbruvica | ||||
| 140 mg tablet | Imbruvica | Imbruvica | Imbruvica | IMBRUVICA ibrutinib 140 mg film-coated tablet blister | Imbruvica | Imbruvica | Imbruvica | Imbruvica 億珂膜衣錠140毫克 | |||
| 280 mg tablet | Imbruvica | Imbruvica | Imbruvica | Imbruvica IMBRUVICA ibrutinib 140 mg film-coated tablet blister | Imbruvica | Imbruvica 億珂膜衣錠280毫克 | |||||
| 420 mg tablet | Imbruvica | Imbruvica | Imbruvica | Imbruvica IMBRUVICA ibrutinib 140 mg film-coated tablet blister | Imbruvica | ||||||
| 560 mg tablet | Imbruvica | Imbruvica | Imbruvica IMBRUVICA ibrutinib 140 mg film-coated tablet blister | Imbruvica | |||||||
| 70 mg liquid | Imbruvica | Imbruvica | |||||||||
| 70 mg capsule | Imbruvica | ||||||||||
unknown | Imbruvica | Imbruvica | Imbruvica |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.